logo

For the Inventor, By the Inventor

Warren, NJ, United States of America

Aquestive Therapeutics, Inc.


USPTO Granted Patents = 25

% Expired Patents = 16.0



Trademarks = 14

Forward Citations = 11

Loading Chart...
Loading Chart...

26 inventors (with patents filed for the assignee):

goldMedal Alexander Mark Schobel (12 out of 32 patents)

silverMedal Stephen Paul Wargacki (9 out of 9 patents)

bronzeMedal Garry L Myers (8 out of 75 patents)

4.  Beuford A Bogue (6 out of 29 patents)

5.  Stephanie Marie Varjan (5 out of 5 patents)

6.  Joseph M Fuisz (4 out of 52 patents)

7.  Richard C Fuisz (4 out of 145 patents)

8.  Robert K Yang (4 out of 35 patents)

9.  Pradeep Sanghvi (3 out of 10 patents)

10.  Vincent J Buono (3 out of 3 patents)

11.  Susan Shumard (3 out of 3 patents)

12.  Christopher James Santee (3 out of 3 patents)

13.  Keith Kendall (3 out of 3 patents)

14.  Dan Barber (3 out of 3 patents)

15.  Theresa Wood (3 out of 3 patents)


Core Competencies:
Linear Polysaccharide
Oral Compositions
Epinephrine Delivery
Prodrug Compositions
Active Dissolution Profiles
Personalized Doses
Rapid-Dissolve Films
Thin Film Technology
Sublingual Compositions
Buccal Films
Anti-Tacking Compositions
Stress Cracking Reduction

25 patents:

1. 12622971 - Linear polysaccharide based film products (2026-05-12),
2. 12465564 - Oral and nasal compositions and methods of treatment (2025-11-11),
3. 12433850 - Enhanced delivery epinephrine and prodrug compositions (2025-10-07),
4. 12427121 - Enhanced delivery epinephrine compositions (2025-09-30),
5. 12403090 - Oral film compositions and dosage forms having precise active dissolution profiles (2025-09-02),
6. 12310922 - System and method for making personalized individual unit doses containing pharmaceutical actives (2025-05-27),
7. 12290597 - Oral film compositions and dosage forms having precise active dissolution profiles (2025-05-06),
8. 12171723 - System and method for making personalized individual unit doses containing pharmaceutical actives (2024-12-24),
9. 12023309 - Enhanced delivery epinephrine compositions (2024-07-02),
10. 11806311 - System and method for making personalized individual unit doses containing pharmaceutical actives (2023-11-07),
11. 11541002 - Oral film compositions and dosage forms having precise active dissolution profiles (2023-01-03),
12. 11273131 - Pharmaceutical compositions with enhanced permeation (2022-03-15),
13. 11207805 - Process for manufacturing a resulting pharmaceutical film (2021-12-28),
14. 11191737 - Enhanced delivery epinephrine compositions (2021-12-07),
15. 11129799 - Dual lane coating (2021-09-28),
Aquestive Therapeutics, Inc. is a biopharmaceutical company based in Warren, New Jersey, specializing in the development of innovative drug delivery technologies. The company focuses on creating solutions that enhance the therapeutic effectiveness of existing medications, particularly for patients with complex medical needs. Their proprietary technologies aim to improve the administration and absorption of drugs, addressing challenges in traditional delivery methods. Aquestive is committed to advancing patient care through its research and development efforts.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

25 Patents

#6 in Warren, NJ

#518 in New Jersey

#13,334 in US

#25,651 in the World

Warren, NJ (US)
Warren, NJ, United States of America

Aquestive Therapeutics, Inc.

Forward Citations = 11

26 inventors:

goldMedal Alexander Mark Schobel (12 out of 32 patents)

silverMedal Stephen Paul Wargacki (9 out of 9 patents)

bronzeMedal Garry L Myers (8 out of 75 patents)

4.  Beuford A Bogue (6 out of 29 patents)

5.  Stephanie Marie Varjan (5 out of 5 patents)

Please report any incorrect information to [email protected]
Loading…